NEWS DESK

ITRM Stock News, News Score & What It Could Mean

ITRM is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.

HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
OPEN ON TRADINGVIEW ↗TRADE THIS STOCK
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
NEWS SCORE
57/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
28
Weak based on actual EPS/revenue
Confidence
Medium
Headline depth
Last Price
$0.03
Trend Context
Mixed / range
Latest briefing

What's happening with ITRM

Yahoo Finance1 Apr 2026

Iterum Therapeutics plc (NASDAQ:ITRM): Are Analysts Optimistic? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQdGFhT1FuWXNNZUJRd3VmelAxcFRYMDh0Rkd2VlZmY3Y2WnUzLUhtTDctQTZHeWJrWmZsc2RoU1BjLXVvTkZIWEVvbWxnNjljX3N0bmNteVMyTWdvaXpGbVphMnItcWdJN1NrZWVRV1FWelJSTkZQejJsYmdXT1hHSm5kZGxsdmE3S3JvV3A2S0FiRTJKeWcyZFppUEZDMkpoeEdwVWtWaw?oc=5" target="_blank">Iterum Therapeutics plc (NASDAQ:ITRM): Are Analysts Optimistic?</a>&nbsp;&nbsp;<font color="#6f6f6f">Yahoo Finance</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Investing.com31 Mar 2026

Iterum Therapeutics to be delisted from Nasdaq as winding up process advances - Investing.com

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxPWXFfdi00VUh5aFdlQUMyLTl2bzM3LThMVldhaGFCZHVPRHlCNFBuN21hUEM5Qnk3dFp2UnhxUEFPcWc0UUpwT0kzNTBBTGluWTNHLURNdDFYRmpULXp3cHlNVlpOaE1IUlgtdHFTaXhzaWhBYnJSMENWejJuTVVSTjNXYm1IWVVYYlNNWC0wSEowVjFnemNmN2ZxQVdLdHcwQ3VFNmdLbEw3Y2doZmh5NlZMTUFIT0NKUVZXZTFLMUlRTWswVTkySDhNWUFsdw?oc=5" target="_blank">Iterum Therapeutics to be delisted from Nasdaq as winding up process advances</a>&nbsp;&nbsp;<font color="#6f6f6f">Investing.com</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
ChartMill30 Mar 2026

Curious about the most active stocks on Monday? - ChartMill

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNVXZtYlFfa3gyaVdtWlNmQTJ2eEZuZXRseE8xV1Y4Uzl3VU1mV3V6TzFVUnBVMzh0eVVhSS1RaFNUNGRNdk91eXg4MzRfdHlES25jeUlkZF9DbUhwbmFDZ2duUlpmZjJ5dDA2aC1oOXB3RERRcGJDQlFJeWlKM2dIdmZlUk54NXJnYVNtN3RoRkd4Z3BMaEt6TnpqaGxYWms?oc=5" target="_blank">Curious about the most active stocks on Monday?</a>&nbsp;&nbsp;<font color="#6f6f6f">ChartMill</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
Stock Titan
27 Mar 2026
Iterum moves toward liquidation as ORLYNVAH faces possible U.S. exit - Stock Titan
Read ↗
Stock Titan
2 Mar 2026
Nasdaq delisting and wind-down risk at Iterum Therapeutics (NASDAQ: ITRM) - Stock Titan
Read ↗
Intellectia AI
16 Feb 2026
ITRM Should I Buy - Intellectia AI
Read ↗
Yahoo Finance
17 Oct 2025
Analysts Expect Breakeven For Iterum Therapeutics plc (NASDAQ:ITRM) Before Long - Yahoo Finance
Read ↗
TradingKey
18 Jun 2026
Iterum Therapeutics PLC (ITRM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Read ↗
Earnings news

ITRM earnings headlines

This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.

1
simplywall.st1 Apr 2026

Breakeven On The Horizon For Iterum Therapeutics plc (NASDAQ:ITRM) - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi6AFBVV95cUxPeGVEcUN3bFRfMTBMemI4MWFObW5adGlsWk96cHYyTWE3QWkzOXZuYTZmdlc1S1pzYkhVeGVNRVdDQlQzSm50TkJueVZmZmtNMnRtY2hqdFdNZEJOUjRuaWk0OFQyRTdZRUtjSHhWdUxpdE9yMUlJRTIzX3lfaHAyRWFqYWNhTTQ2RFFyZHdyYk0tRnFMVkZxd3g4cU5VMUtsRDNLWjMzVldDMFBCczI4aXI4MlZtWXplcDRNV3VGbzJYMlZZRFhqTTRnYnJDRlBxcGlvY1I1b3BBUFl1SHBIVEZYNkJ6ZTdl0gHuAUFVX3lxTE1MS2YtMFFnenowTFhDR0ZMQ2REdnQ1eU1CeWVfYmIzdS0zaWlDWDkzQ3g2cUZrVHZCRVNiNXV5UGpxU3RjSHNmMzctNnI5YlZLM1NQZVl0V0laTVFtc1djd0p1QWRLd1JXeDZrQzdrMzI1Tm5HYkk2aEZlZ2h5ZzBfMHJ4MVB2RmktSW83d0xTZ2Q4bUZHV09yN25QcGgwOWk2WmNzYktRb1lUeVpIQjRVYzJ3THIwbVM0ZURzXzBFVUtoc1VycFBLbU10eWRRYWNqc3RLMWE5NmFoQURyWkNHRjY5aUlKRWpnT2dEYnc?oc=5" target="_blank">Breakeven On The Horizon For Iterum Therapeutics plc (NASDAQ:ITRM)</a>&nbsp;&nbsp;<font color="#6f6f6f">simplywall.st</font>

2
Investing.com31 Mar 2026

Iterum Therapeutics to be delisted from Nasdaq as winding up process advances - Investing.com

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxPWXFfdi00VUh5aFdlQUMyLTl2bzM3LThMVldhaGFCZHVPRHlCNFBuN21hUEM5Qnk3dFp2UnhxUEFPcWc0UUpwT0kzNTBBTGluWTNHLURNdDFYRmpULXp3cHlNVlpOaE1IUlgtdHFTaXhzaWhBYnJSMENWejJuTVVSTjNXYm1IWVVYYlNNWC0wSEowVjFnemNmN2ZxQVdLdHcwQ3VFNmdLbEw3Y2doZmh5NlZMTUFIT0NKUVZXZTFLMUlRTWswVTkySDhNWUFsdw?oc=5" target="_blank">Iterum Therapeutics to be delisted from Nasdaq as winding up process advances</a>&nbsp;&nbsp;<font color="#6f6f6f">Investing.com</font>

Beyond the headline

A deeper look for beginners

Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.

Continue your ITRM research
Use the stock analysis page for a fuller technical read, open TradingView for charting, or head to Platforms when you are ready to place a trade.
Stock AnalysisOPEN ON TRADINGVIEW ↗TRADE THIS STOCK